Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0PLOS One

Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer

  1. 1Facultad de Ingenieria y Ciencias, Univesidad Adolfo Ibañez, Santiago, Chile
  2. 2Laboratoire d’Informatique et Systèmes, Centre National de la Recherche Scientifique, Aix-Marseille Univesité, Marseille, France
  3. 3Millennium Nucleus for Social Data Science (SODAS), Santiago, Chile

Abstract

Boolean networks are powerful frameworks for capturing the logic of gene-regulatory circuits, yet their combinatorial explosion hampers exhaustive analyses. Here, we present a systematic reduction of a published 31-node Boolean model that describes cisplatin- and pemetrexed-resistance in non-small-cell lung cancer to a compact 9-node core that exactly reproduces the original attractor landscape. Through a sequence of biologically guided reductions (31→29→14→9 nodes), the streamlined network shrinks the state space by four orders of magnitude, enabling rapid exploration of critical control points, rules fitting, and candidate therapeutic targets. Extensive synchronous and asynchronous simulations, combined with a Boolean rule-fitting algorithm that removes spurious limit cycles, confirm that the three clinically relevant steady states and their basins of attraction are conserved and reflect resistance frequencies close to those reported in clinical studies. The reduced model provides an accessible scaffold for future mechanistic and drug-discovery studies.

Related

  1. Scalable and semi-automated Boolean network inference from multi-condition single-cell transcriptomes with scBOLT
    T. Roncalli, E. Remy, L. Pauleve
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxiv
  2. A multiscale pharmacokinetic-Boolean modelling framework for ibrutinib resistance in a Chronic Lymphocytic Leukaemia case study
    M. Marku, C. Pineau, M. Hurtado +6
    bioRxivPreprintCC BY-NC-NDFull textSystems & synthetic biologybioRxiv
  3. Regional and network-level resting state functional connectivity markers of pharmacological treatment resistance in obsessive-compulsive disorder
    H. Chhabra, S. Balachander, V. H. Thimmashetty +5
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  4. Effective Resistance and Graph Neural Network Reliability in Tissue-Specific Interactomes
    Jianru Shen
    arXivPreprintarXiv licenceFull textSystems & synthetic biologyarXiv
  5. Streptavidins Coordinate Biotin Sequestration and Self‐Resistance Within a Biotin‐Pathway Antibiotic Network
    Sumire Kurosawa, Jingjun Mo, Xiaotong Diao +6
    Advanced SciencePeer-reviewedCC BY5 citedMicrobiologyOpenAlex
BibTeX
@article{espinoza2026booleannetwork,
  title = {{Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer}},
  author = {Alonso Espinoza and Eric Goles and Marco Montalva-Medel},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0357764},
  url = {https://doi.org/10.1371/journal.pone.0357764},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer
AU  - Alonso Espinoza
AU  - Eric Goles
AU  - Marco Montalva-Medel
PY  - 2026
DA  - 2026/09/15
JO  - PLOS One
DO  - 10.1371/journal.pone.0357764
UR  - https://doi.org/10.1371/journal.pone.0357764
AB  - Boolean networks are powerful frameworks for capturing the logic of gene-regulatory circuits, yet their combinatorial explosion hampers exhaustive analyses. Here, we present a systematic reduction of a published 31-node Boolean model that describes cisplatin- and pemetrexed-resistance in non-small-cell lung cancer to a compact 9-node core that exactly reproduces the original attractor landscape. Through a sequence of biologically guided reductions (31→29→14→9 nodes), the streamlined network shrinks the state space by four orders of magnitude, enabling rapid exploration of critical control points, rules fitting, and candidate therapeutic targets. Extensive synchronous and asynchronous simulations, combined with a Boolean rule-fitting algorithm that removes spurious limit cycles, confirm that the three clinically relevant steady states and their basins of attraction are conserved and reflect resistance frequencies close to those reported in clinical studies. The reduced model provides an accessible scaffold for future mechanistic and drug-discovery studies.
SN  - 1932-6203
ER  -